LITTLE KNOWN FACTS ABOUT LINK ALTERNATIF MBL77.

Not all sufferers with CLL involve therapy. Irrespective of all new developments, the iwCLL however recommends watchful observation for sufferers with asymptomatic disease.86 This suggestion is based on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Moreover